• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

急性冠状动脉综合征后危险因素控制与主要不良心血管事件的关系:拉丁美洲单中心经验。

Risk Factors Control After an Acute Coronary Syndrome and Association with Major Adverse Cardiovascular Events: A Single Center Experience in Latin-America.

机构信息

Ischemic Cardiomyopathy Clinic, Instituto Nacional de Cardiologia Ignacio Chavez, Mexico City, Mexico.

Anesthesiology Department, Hospital General Manuel Gea Gonzalez, Mexico City, Mexico.

出版信息

High Blood Press Cardiovasc Prev. 2023 Mar;30(2):183-189. doi: 10.1007/s40292-023-00560-x. Epub 2023 Feb 3.

DOI:10.1007/s40292-023-00560-x
PMID:36735221
Abstract

INTRODUCTION

An important challenge in the secondary prevention of cardiovascular diseases is the optimization of risk factors (RFs) after hospital discharge. These have been shown to be insufficiently controlled in clinical practice.

AIM

To evaluate whether secondary prevention goals were met at our institution at 12 months after an acute coronary syndrome (ACS) index event, as well as analyzing if achieving these goals was associated with a lower incidence of major adverse cardiovascular events (MACE).

METHODS

Retrospective cohort of patients with a former diagnosis of ACS over a period of 4 years. To evaluate the proportion of patients who met RF control goals at 12 months after the index event, we used two sets of preestablished goals: stringent and lenient. During follow-up we evaluated the occurrence of MACE, defined by the following: ACS, coronary revascularization, stroke, hospitalization because of acute heart failure and cardiovascular death.

RESULTS

We included 468 patients during the study period. The mean age of the patients was 60 ± 10.76 years, 20.5% were women, and mean follow-up was 41.8 ± 22.0 months. The proportion of patients that met all secondary prevention stringent and lenient goals accounted for 5.5% and 17.2%, respectively, and 8% did not achieve any target. Overall, 9.6% presented the composite of MACE during follow-up. The number of RFs in control at 12 months was associated with a lower rate of MACE, both with stringent and lenient goals.

CONCLUSION

Achieving established goals for modifiable RFs can lower the incidence of MACE during long-term follow-up.

摘要

简介

心血管疾病二级预防的一个重要挑战是优化出院后的危险因素(RFs)。临床实践中这些因素的控制并不充分。

目的

评估在急性冠状动脉综合征(ACS)指数事件后 12 个月,我们机构的二级预防目标是否得到满足,并分析达到这些目标是否与主要不良心血管事件(MACE)发生率降低相关。

方法

对过去 4 年中曾诊断为 ACS 的患者进行回顾性队列研究。为了评估指数事件后 12 个月达到 RF 控制目标的患者比例,我们使用了两套预先设定的目标:严格和宽松。在随访期间,我们评估了 MACE 的发生情况,定义为 ACS、冠状动脉血运重建、中风、因急性心力衰竭住院和心血管死亡。

结果

在研究期间,我们纳入了 468 名患者。患者的平均年龄为 60±10.76 岁,20.5%为女性,平均随访时间为 41.8±22.0 个月。严格和宽松的二级预防目标均达到的患者比例分别为 5.5%和 17.2%,8%的患者未达到任何目标。总体而言,9.6%的患者在随访期间发生了 MACE 复合事件。12 个月时 RF 控制数量与 MACE 发生率降低相关,无论是严格还是宽松的目标。

结论

达到既定的可改变 RFs 目标可以降低长期随访期间 MACE 的发生率。

相似文献

1
Risk Factors Control After an Acute Coronary Syndrome and Association with Major Adverse Cardiovascular Events: A Single Center Experience in Latin-America.急性冠状动脉综合征后危险因素控制与主要不良心血管事件的关系:拉丁美洲单中心经验。
High Blood Press Cardiovasc Prev. 2023 Mar;30(2):183-189. doi: 10.1007/s40292-023-00560-x. Epub 2023 Feb 3.
2
A risk score to predict postdischarge bleeding among acute coronary syndrome patients undergoing percutaneous coronary intervention: BRIC-ACS study.BRIC-ACS 研究:一种预测行经皮冠状动脉介入治疗的急性冠状动脉综合征患者出院后出血风险的评分。
Catheter Cardiovasc Interv. 2019 Jun 1;93(7):1194-1204. doi: 10.1002/ccd.28325. Epub 2019 May 21.
3
Short-term outcome and attainment of secondary prevention goals in patients with acute coronary syndrome--results from the countrywide TARGET study.急性冠状动脉综合征患者的短期预后和二级预防目标的实现——来自全国 TARGET 研究的结果。
Int J Cardiol. 2013 Sep 30;168(2):922-7. doi: 10.1016/j.ijcard.2012.10.049. Epub 2012 Nov 25.
4
Worse outcomes of ACS patients without versus with traditional cardiovascular risk factors.不伴有传统心血管危险因素的 ACS 患者的预后更差。
J Cardiol. 2022 Apr;79(4):515-521. doi: 10.1016/j.jjcc.2021.10.019. Epub 2021 Nov 17.
5
Preventable clinical and psychosocial factors predicted two out of three recurrent cardiovascular events in a coronary population.可预防的临床和心理社会因素可预测冠状动脉人群中三分之二的复发性心血管事件中的两起。
BMC Cardiovasc Disord. 2020 Feb 5;20(1):61. doi: 10.1186/s12872-020-01368-6.
6
The burden of major adverse cardiac events in patients with coronary artery disease.冠状动脉疾病患者主要不良心脏事件的负担
BMC Cardiovasc Disord. 2017 Jan 4;17(1):1. doi: 10.1186/s12872-016-0436-7.
7
Influence of sex, age and race on coronary and heart failure events in patients with diabetes and post-acute coronary syndrome.性别、年龄和种族对糖尿病合并急性冠脉综合征患者的冠脉和心力衰竭事件的影响。
Clin Res Cardiol. 2021 Oct;110(10):1612-1624. doi: 10.1007/s00392-021-01859-2. Epub 2021 Apr 30.
8
WBC count predicts heart failure in diabetes and coronary artery disease patients: a retrospective cohort study.白细胞计数可预测糖尿病合并冠心病患者的心力衰竭:一项回顾性队列研究。
ESC Heart Fail. 2021 Oct;8(5):3748-3759. doi: 10.1002/ehf2.13513. Epub 2021 Jul 15.
9
Association of Initial and Serial C-Reactive Protein Levels With Adverse Cardiovascular Events and Death After Acute Coronary Syndrome: A Secondary Analysis of the VISTA-16 Trial.初始和连续 C 反应蛋白水平与急性冠状动脉综合征后不良心血管事件和死亡的关系:VISTA-16 试验的二次分析。
JAMA Cardiol. 2019 Apr 1;4(4):314-320. doi: 10.1001/jamacardio.2019.0179.
10
Gender Difference in Secondary Prevention of Cardiovascular Disease and Outcomes Following the Survival of Acute Coronary Syndrome.性别差异与急性冠状动脉综合征存活后的心血管疾病二级预防及结局
Heart Lung Circ. 2021 Jan;30(1):121-127. doi: 10.1016/j.hlc.2020.06.026. Epub 2020 Sep 2.

引用本文的文献

1
Adherence to optimal medical therapy and control of cardiovascular risk factors in patients after ST elevation myocardial infarction in Mexico.墨西哥ST段抬高型心肌梗死患者对最佳药物治疗的依从性及心血管危险因素的控制
Front Cardiovasc Med. 2024 Jul 23;11:1384684. doi: 10.3389/fcvm.2024.1384684. eCollection 2024.

本文引用的文献

1
Effect of metabolic control on recurrent major adverse cardiovascular events and cardiovascular mortality in patients with premature coronary artery disease: Results of the Genetics of Atherosclerotic Disease study.代谢控制对早发冠心病患者复发性主要不良心血管事件和心血管死亡率的影响:动脉粥样硬化性疾病遗传学研究结果。
Nutr Metab Cardiovasc Dis. 2022 Sep;32(9):2227-2237. doi: 10.1016/j.numecd.2022.06.008. Epub 2022 Jun 15.
2
Prevalence and characterization of undiagnosed arterial hypertension in the eastern zone of Mexico.墨西哥东部地区未确诊动脉高血压的患病率和特征。
J Clin Hypertens (Greenwich). 2022 Feb;24(2):131-139. doi: 10.1111/jch.14414. Epub 2021 Dec 28.
3
2021 ESC Guidelines on cardiovascular disease prevention in clinical practice.
2021年欧洲心脏病学会临床实践中心血管疾病预防指南。
Eur Heart J. 2021 Sep 7;42(34):3227-3337. doi: 10.1093/eurheartj/ehab484.
4
Usefulness of the corporate wellness projects in primary prevention at the population level: a study on the prevalence, awareness, and control of hypertension in the Ferrari company.企业健康项目在人群层面一级预防中的效用:法拉利公司高血压患病率、知晓率及控制情况的研究
J Hum Hypertens. 2022 Mar;36(3):308-314. doi: 10.1038/s41371-021-00528-1. Epub 2021 Mar 23.
5
2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation.2020年欧洲心脏病学会非持续性ST段抬高型急性冠状动脉综合征患者管理指南
Eur Heart J. 2021 Apr 7;42(14):1289-1367. doi: 10.1093/eurheartj/ehaa575.
6
2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk.2019年欧洲心脏病学会/欧洲动脉粥样硬化学会血脂异常管理指南:通过血脂修饰降低心血管风险
Eur Heart J. 2020 Jan 1;41(1):111-188. doi: 10.1093/eurheartj/ehz455.
7
Efficacy and safety of dual combination therapy of blood pressure-lowering drugs as initial treatment for hypertension: a systematic review and meta-analysis of randomized controlled trials.降压药物联合治疗作为高血压初始治疗的疗效和安全性:系统评价和随机对照试验的荟萃分析。
J Hypertens. 2019 Sep;37(9):1768-1774. doi: 10.1097/HJH.0000000000002096.
8
New approach to blood pressure control: Triple combination pill.控制血压的新方法:三联复方片剂。
Trends Cardiovasc Med. 2020 Feb;30(2):72-77. doi: 10.1016/j.tcm.2019.03.002. Epub 2019 Mar 14.
9
Lifestyle and impact on cardiovascular risk factor control in coronary patients across 27 countries: Results from the European Society of Cardiology ESC-EORP EUROASPIRE V registry.27 个国家的冠心病患者生活方式及对心血管危险因素控制的影响:欧洲心脏病学会 ESC-EORP EUROASPIRE V 注册研究结果。
Eur J Prev Cardiol. 2019 May;26(8):824-835. doi: 10.1177/2047487318825350. Epub 2019 Feb 10.
10
Highlights of ESC/ESH 2018 Guidelines on the Management of Hypertension: What Every Doctor Should Know.《2018年欧洲心脏病学会/欧洲高血压学会高血压管理指南要点:每位医生都应知晓的内容》
High Blood Press Cardiovasc Prev. 2019 Feb;26(1):1-8. doi: 10.1007/s40292-018-00297-y. Epub 2019 Jan 2.